Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population

Infection Control and Hospital Epidemiology

Volumn 23, Issue 10, 2002, Pages 604-608

  Hirji, Z ^a   O'grady S ^a   Bonham, J ^a   Mak, M ^a   Takata Shewchuk, J ^a   Hawkins, K ^a   Gardam, M ^a   Law, L ^a   Mazzulli, T ^a   Conly, J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ZANAMIVIR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; FEMALE; HOSPITAL CARE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SORE THROAT;

EID: 0036794532     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501979     Document Type: Article

References (10)

1. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518-527.
2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-4):1-28.
3. Waghorn SL, Goa KL. Zanamivir. Drugs 1998;55:721-725.
4. Campion K, Silagy C, Cooper C, et al. Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections: the MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998;352:1877-1881.
5. Monto A, Robinson D, Herlocher M, et al. Zanamivir in the prevention of influenza among healthy adults. JAMA 1999;282:31-35.
6. Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med 2001;161:212-217.
7. Katz S. The index of ADL: a standardized measure of biological and psychological function. JAMA 1963;185:914-919.
8. Ziegler T, Cox N. Influenza viruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7th ed. Washington, DC: ASM Press; 1999:928-935.
9. Patriarca PA, Arden NH, Koplan JP, et al. Prevention and control of type A influenza infections in nursing homes: benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 1987;107:732-740.
10. Lee C, Loeb M, Phillips A, et al. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol 2000;21:700-704.